MA
About
Mirae Asset Capital Life Science is focused on investing in life science. It was created as a joint venture between Mirae Asset Capital and Mirae Asset Global Investments. The group invests in companies working on drug development and clinical research. Its work includes supporting treatments for autoimmune diseases. The company reviews market data to guide its investment decisions. The portfolio includes organizations such as Accent Therapeutics.
Position in the VCSift Database
- • 33,888 investors in VCSift focus on the fintech sector.
- • 10,621 investors are based in New York, New York, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Stages
- series-c
- Sectors
- fintech healthtech
- Location
- New York, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Mirae
Search Investors